Vera Therapeutics Inc — We expect our key phase 3 Origin 3 trial to deliver key endpoint results in the first half of 2025
Vera Therapeutics Inc——2025年上半年我们预计我们的关键3期Origin 3试验将得出主要终点结果
Vera Therapeutics Inc — We expect our key phase 3 Origin 3 trial to deliver key endpoint results in the first half of 2025
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.